THERAPY WITH CINACALCET IN KIDNEY TRANSPLANTED PATIENTS WITH SECONDARY HYPERPARATHYROIDISM: EFFICACY AND SAFETY

被引：0
|
作者：
Escuin, Fernando [1 ]
Jimenez, Carlos [1 ]
Gonzalez, Elena [1 ]
Ossorio, Marta [1 ]
Lopez, Maria [1 ]
Azorin, Sebastian [1 ]
Miguel, Jose Luis [1 ]
Selgas, Rafael [1 ]
机构：
[1] Hosp Univ La Paz, Madrid, Spain
来源：
TRANSPLANT INTERNATIONAL | 2009年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：361 / 362
页数：2
相关论文
共 50 条
  • [21] Association of Nodular Hyperplasia With Resistance to Cinacalcet Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients
    Hirai, Takayuki
    Nakashima, Ayumu
    Takasugi, Norihisa
    Yorioka, Noriaki
    THERAPEUTIC APHERESIS AND DIALYSIS, 2010, 14 (06) : 577 - 582
  • [22] Role of cinacalcet in the treatment of secondary hyperparathyroidism in chronic kidney disease
    Aggarwal, H. K.
    Jain, Deepak
    Kaverappa, Vipin
    Kaushik, Sumin
    Yadav, Sachin
    RUSSIAN OPEN MEDICAL JOURNAL, 2013, 2 (03)
  • [23] Efficacy and Safety Analysis of Alfacalcidol Combined with Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Renal Failure in Maintenance Hemodialysis
    Tong, Jin
    Zheng, Xiafang
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 226 - 231
  • [24] Phase 3 study results demonstrate efficacy and safety of the calcimimetic cinacalcet HCI in hemodialysis patients with secondary hyperparathyroidism (HPT).
    Block, GA
    Martin, KJ
    Turner, SA
    Avram, MM
    Hercz, G
    Abu-Alfa, AK
    Coyne, DW
    Cohen, RM
    Moe, SM
    McCary, LC
    Olson, KA
    Goodman, WG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 461A - 461A
  • [25] Efficacy of cinacalcet in the treatment of calcitriol-resistant secondary hyperparathyroidism
    Franco, Cadinu
    Giovanni, Mattana
    Agostina, Leoni
    Patrizia, Vatieri
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 415 - 415
  • [26] Experience with Cinacalcet for Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Stage III and IV
    Forslund, Terje
    Koistinen, Arvo
    Miettinen, Marja
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 801 - 808
  • [27] Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet
    Guerra, Rita
    Auyanet, Ingrid
    Fernandez, Ernesto J.
    Angel Perez, Miguel
    Bosch, Elvira
    Ramirez, Ana
    Suria, Santiago
    Dolores Checa, Maria
    JOURNAL OF NEPHROLOGY, 2011, 24 (01) : 78 - 82
  • [28] Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysis
    Sun, Yiting
    Tian, Binyao
    Sheng, Zitong
    Wan, Pengzhi
    Xu, Tianhua
    Yao, Li
    BMC NEPHROLOGY, 2020, 21 (01)
  • [29] Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysis
    Yiting Sun
    Binyao Tian
    Zitong Sheng
    Pengzhi Wan
    Tianhua Xu
    Li Yao
    BMC Nephrology, 21
  • [30] The efficacy of cinacalcet combined with conventional therapy on bone and mineral metabolism in dialysis patients with secondary hyperparathyroidism: a meta-analysis
    Dan Li
    Leping Shao
    Haiyan Zhou
    Wei Jiang
    Wei Zhang
    Yan Xu
    Endocrine, 2013, 43 : 68 - 77
12345